The Food and Drug Administration (FDA) has approved a new polypill that combines telmisartan, amlodipine, and indapamide for the treatment of hypertension in adults, including use as an initial therapy. This is the first FDA-approved triple-combination medication indicated for initial use in patients who are likely to require multiple drugs to reach their blood pressure goals, according to a press release from manufacturer George Medicines. Most patients with hypertension ultimately need 2 or more medications …
Read More
